UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT ~~PURSUANT~~Pursuant TOto ~~SECTION~~ Section 13 ORor 15(Dd) OFof ~~THE SECURITIES~~the ~~EXCHANGE~~Securities ~~ACT~~Exchange OFAct of 1934

Date of ~~report~~Report (Date of earliest event reported): ~~April~~ June 2514, 2005

Renal Care Group, Inc.

(Exact ~~Name~~name of ~~Registrant~~registrant as ~~Specified~~specified in its ~~Charter~~charter)

Delaware (State or ~~Other~~other ~~Jurisdiction~~jurisdiction of ~~Incorporation~~incorporation) 0000-27640 (Commission File Number) 62-1622383 (I.R.S. Employer Identification No.)

2525 West End Avenue, Suite 600, Nashville, Tennessee 37203 (Address of ~~Principal~~principal ~~Executive~~executive ~~Offices~~offices) ~~37203 (Zip Code)~~

(615) 345-5500
(Registrant’s telephone number, including area code)

~~Check~~(Former ~~the~~name ~~appropriate~~or ~~box~~former ~~below~~address, if ~~the~~changed ~~Form~~since ~~8-K~~last ~~filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below~~report):

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~TABLE ~~8.01~~OF ~~Other Events.~~CONTENTS

On April 25, 2005, Renal Care Group, Inc. (“the Company”) announced that effective May 30, 2006, Raymond M. Hakim, M.D., Ph.D., plans to resign from his duties as Senior Executive Vice President of Clinical Affairs and Chief Medical Officer. In the interim, Dr. Hakim will work with the Company to identify and recruit a new Chief Medical Officer.


	ITEM 8.01 OTHER EVENTS
	ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
SIGNATURE
EXHIBIT INDEX
EX-99.1 RELEASE, DATED JUNE 14, 2005, ENTITLED "RENAL CARE GROUP RECEIVES SECOND REQUEST FROM THE FEDERAL TRADE COMMISSION REGARDING PENDING ACUISITION"

~~Item~~ITEM 98.01 ~~Financial~~OTHER ~~Statements and Exhibits.~~EVENTS

On June 14, 2005 Renal Care Group, Inc. announced that it has received a request from the Federal Trade Commission for additional information in connection with the proposed acquisition of Renal Care Group, Inc. by Fresenius Medical Care AG. A copy of the ~~Company’s~~ press release ~~concerning~~announcing ~~Dr. Hakim’s~~the receipt ~~resignation~~of the request for additional information is attached hereto as Exhibit 99.1 toand ~~this~~is incorporated ~~Current~~herein ~~Report~~by ~~on Form 8-K~~reference.

~~SIGNATURE~~ ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized~~ (c) Exhibits.

~~RENAL~~99.1 ~~CARE~~Release, ~~GROUP~~dated June 14, ~~INC.~~2005, ~~By:~~entitled ~~/s/~~“Renal ~~David~~Care M.Group ~~Dill~~Receives ~~David~~Second M.Request ~~Dill~~From ~~Executive~~the ~~Vice~~Federal ~~President~~Trade ~~and~~Commission ~~Chief~~Regarding ~~Financial~~Pending ~~Officer~~Acquisition”

~~Dated: April 25, 2005~~SIGNATURE

~~INDEX~~ Pursuant TOto ~~EXHIBITS~~the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT NO.	DESCRIPTION
	Renal Care Group, Inc.
99.1	Press Release, dated April 25, 2005
Date: June 15, 2005	By:	/s/ David M. Dill
	Name:	David M. Dill
	Title:	Executive Vice President and Chief Financial Officer

-2-

EXHIBIT INDEX


Exhibit
Number		Description
99.1		Release, dated June 14, 2005, entitled “Renal Care Group Receives Second Request From the Federal Trade Commission Regarding Pending Acquisition”

-3-

Filing Compare · RENAL CARE GROUP INC